[Webinar] How to better optimize an oncology drug discovery program
Register for this webinar discussing how conventional and innovative integrated technological skills should be incorporated into an oncology program.
Read more 
SOLO Pharmaco-imaging: Imaging studies to support proof of concept in in vivo and in vitro pharmacology
SOLO Pharmaco-Imaging is a service offering from Oncodesign’s Pharmimage® technology module – a module which uses non-invasive preclinical imaging to monitor the expression and engagement of in vivo targets, the biodistribution of compounds, the effect of therapeutic treatments, their mechanism of action and pharmacodynamics. This module also serves to identify and define translational biomarkers for patient stratification and therapeutic response activity/efficacy in precision medicine.
Non-invasive techniques to complement biodistribution studies and biomarker assessment
Our SOLO Pharmaco-Imaging service offering gives you access to multi-modal imaging capabilities, adapted to small rodents and primates:
- Optical imaging: bioluminescence, fluorescence
- Functional and molecular imaging: MRI, PET, SPECT, CT scanner, MRI/PET coupling.
You benefit from a range of methods of vectorized radiotherapy and radiolabeling of chemical or biological molecules (peptides, antibodies or others) tailored for the study of pharmacokinetics and mechanisms.
Our expertise in multi-modal pharmaco-imaging for your preclinical and clinical projects
We support you in the conception, design and implementation of preclinical translational pharmaco-imaging studies in your research programs, in diverse therapeutic indications and at different stages of discovery and development.
Our technologies are adapted to preclinical studies and are comparable to those used in clinical nuclear medicine.
